Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort

NCT02910037
unknownnot_applicable

Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases

NCT04125654
unknownnot_applicable

Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis

NCT04195724

Clinical Trials (3)

Showing 3 of 3 trials
NCT02910037Not Applicable

Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort

Completed
NCT04125654Not Applicable

Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases

Unknown
NCT04195724Not Applicable

Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3